Reactive arthritis with SARS-COV-2 as a trigger

Ruiz-Del-Valle, Víctor; Ardanaz, Luis Sarabia de; Navidad-Fuentes, Miriam; Martín-Martín, Irene; Lobato-Cano, Rubén

doi:10.1016/j.reumae.2021.11.002

Cited by 5 publications

(7 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The detailed quality assessment results of the studies are available in Supporting Information: S3 File. Three studies had excellent quality, 51 , 52 , 53 27 studies had good quality, 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 55 14 studies had satisfactory quality, 30 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 55 and two studies had unsatisfactory quality, 49 , 50 according to JBI critical appraisal checklist for case reports and case reports.…”

Section: Resultsmentioning

confidence: 99%

“…The detailed quality assessment results of the studies are available in Supporting Information: File. Three studies had excellent quality, 51–53 27 studies had good quality, 10–35,55 14 studies had satisfactory quality, 30,36–48,55 and two studies had unsatisfactory quality, 49,50 according to JBI critical appraisal checklist for case reports and case reports.…”

Section: Resultsmentioning

confidence: 99%

“…Cases with post‐COVID arthritis, including case reports, case series, letters, editorial papers, comments, and conferences, were included for eligibility assessment, and documents with inadequate clinical data were excluded. Finally, 41 case reports (45 patients, Table 1 ) 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 and 5 case series (50 patients, Table 2 ), 51 , 52 , 53 , 54 , 55 with a total number of 95 patients (46 studies), were included in this systematic review. The flow diagram for the search of databases is given in Figure…”

Section: Resultsmentioning

confidence: 99%

“…12 Dactylitis, another peri-articular manifestation, was noted in 1 patient without arthritis. 40 Extra-articular manifestations like skin rashes, 11,34,35,39,50,53 conjunctivitis, 29,30,53 diarrhea, 24,37,46 balanitis, 29,49 psoriatic skin lesions, 12 and silent thyroiditis 32 were seen in 15 patients; no positive STD test was documented. Additionally, 20 patients underwent the HLA-B27, and 6 patients had a positive 24,27,28,30,52 ; 72 patients had done other rheumatologic auto-antibodies tests, and 6 patients had a positive result.…”

Section: Covid-associated Arthritis After Non-severe Covid-19mentioning

confidence: 99%

See 3 more Smart Citations

COVID‐associated arthritis after severe and non‐severe COVID‐19: A systematic review

Zarpoosh,

Amirian

2023

Immunity Inflam & Disease

View full text Add to dashboard Cite

AimSince the coronavirus outbreak became a global health emergency in 2020, various immune‐based effects, such as inflammatory arthritis (IA), have been recorded. This study aimed to determine the role of COVID‐19 severity on post‐COVID arthritis.MethodsWe systematically reviewed 95 patients who developed arthritis after severe and non‐severe COVID‐19 infection by searching the databases, including PubMed, SCOPUS, and EMBASE. We used the term “COVID‐associated arthritis” because there was no definite diagnostic method for classifying arthritides after COVID‐19 infection, and the diagnosed arthritis types were based on the authors' viewpoints.ResultsAfter evaluating the data between the two severe and non‐severe COVID‐19‐infected groups of patients, the results showed that the COVID‐19 severity may affect the pattern of joint involvement in IA. In both groups, combination therapy, including oral nonsteroidal anti‐inflammatory drugs with different types of corticosteroids, was the most common treatment. In addition, the mean age and comorbidities rate was higher in the severe COVID‐19 group. Even though the patients in the severe COVID‐19 group developed more serious COVID‐19 symptoms, they experienced milder arthritis with better outcomes and more delayed onsets that required less aggressive therapy.ConclusionWe conclude that there may be an inverse relationship between COVID‐19 severity and arthritis severity, possibly due to weaker immunity conditions following immunosuppressant treatments in patients with severe COVID‐19.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Covid-associated Arthritis After Non-severe Covid-19mentioning

confidence: 99%

See 2 more Smart Citations

COVID‐associated arthritis after severe and non‐severe COVID‐19: A systematic review

Zarpoosh,

Amirian

2023

Immunity Inflam & Disease

View full text Add to dashboard Cite

show abstract

“…The exact terminology varied between studies and, for the purposes of this review, reported iRMDs have been grouped according to the ICD‐11 categories: RA, polymyalgia rheumatica and giant cell arteritis, adult‐onset Still disease, juvenile idiopathic arthritis, inflammatory spondylarthritis, SLE, systemic sclerosis, idiopathic inflammatory myopathy, vasculitis, psoriatic arthritis, direct infection of joint, and inflammatory arthropathies unspecified. In the case reports and case series, the most commonly reported iRMDs were “reactive arthropathies” (n = 47), 14,22–43 followed by “inflammatory arthropathies unspecified” (n = 18), 15,23,24,38,44–52 RA (n = 12), 53–62 and SLE (n = 11) 6,59,63–71 . The single observational (cross‐sectional) study by Taha et al reported that following an episode of COVID‐19, 37 out of 100 people observed (37%) developed “post COVID arthritis.” 72 …”

Section: Resultsmentioning

confidence: 99%

Summarizing Evidence of Associations of COVID‐19 With a Future Diagnosis of Inflammatory Rheumatic and Musculoskeletal Diseases: A Rapid Review

Mudge,

Honey,

Tachoukaft

et al. 2023

Arthritis Care & Research

View full text Add to dashboard Cite

Musculoskeletal symptoms are commonly reported following acute coronavirus disease 2019 (COVID‐19). It is unclear whether those with musculoskeletal symptoms subsequently develop inflammatory rheumatic musculoskeletal disease (iRMD). This review seeks to identify evidence for an association between acute COVID‐19 and subsequent iRMD diagnosis. A rapid review of the literature using a systematic search of Medline, EMBASE and two COVID‐19 databases was undertaken until August 2022. Case studies, case series, cross‐sectional, case‐control, and cohort studies reporting patients with an incident iRMD following COVID‐19 were included. Title and abstract screening were conducted by one reviewer, and full text screening by two reviewers. Data extraction and quality appraisal were by one reviewer, with a second verifying. Study‐type specific critical appraisal tools were used. Results were narratively synthesised. 80 studies were included (69 case reports, 10 case series and 1 cross‐sectional study). Commonly reported iRMDs were ‘reactive arthropathies’ (studies=47), ‘inflammatory arthropathies unspecified’ (studies=18), rheumatoid arthritis (studies=12) and lupus erythematosus (studies=11). The cross‐sectional study reported 37% of those with COVID‐19 developed ‘post‐covid arthritis.’ Time from diagnosis of COVID‐19 to iRMD presentation ranged from 0‐120 days. Several mechanisms were proposed to explain the association between COVID‐19 and iRMD development: auto‐immune processes, aberrant inflammatory responses, colonisation of joint spaces, direct damage from the SARS‐CoV2 virus and genetic predisposition. The level of evidence of the studies included in this review was low, and the quality generally poor. Prospective observational studies are required to confirm associations and likely impact of post COVID‐19 iRMDs at a population level.

show abstract

Rheuma nach COVID-19-Infektion oder Impfung

Herold

2023

J. Miner. Stoffwechs. Muskuloskelet. Erkrank.

View full text Add to dashboard Cite

ZusammenfassungSowohl nach COVID-Infektion als auch nach ein oder mehreren COVID-Impfungen können rheumatische Beschwerden beginnen. In beiden Fällen scheint der Mechanismus ähnlich zu sein und mit dem Coronavirus oder seinen spezifischen Folgen zusammenzuhängen. Zumeist wird von einer reaktiven Arthritis gesprochen, wenngleich die Bezeichnung COVID-19-assoziierte Arthritis für das Beschwerdebild eher zutreffen dürfte. In Relation zur Zahl der COVID-Infizierten und der COVID-geimpften ist die Zahl der Fälle, in denen es zu COVID-assoziierten Beschwerden kommt, außerordentlich gering und die Prognose scheint eher gut zu sein.

show abstract

Reactive arthritis with SARS-COV-2 as a trigger

Cited by 5 publications

References 6 publications

COVID‐associated arthritis after severe and non‐severe COVID‐19: A systematic review

COVID‐associated arthritis after severe and non‐severe COVID‐19: A systematic review

Summarizing Evidence of Associations of COVID‐19 With a Future Diagnosis of Inflammatory Rheumatic and Musculoskeletal Diseases: A Rapid Review

Rheuma nach COVID-19-Infektion oder Impfung

Contact Info

Product

Resources

About